1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 2: Recurrence rates among the NI-RADS categories
NI-RADS Categories Total Recurrence Rate (No.) Primary site NI-RADS 1 254 3.5% (9) NI-RADS 2 38 18.4% (7) NI-RADS 3 22 54.6% (12) All primary site categories 314 8.9% (28) Lymph nodes NI-RADS 1 274 4.0% (11) NI-RADS 2 20 15.0% (3) NI-RADS 3 10 70.0% (7) All nodal categories 304 6.9% (21) Combined primary and nodes NI-RADS 1 528 3.8% (20) NI-RADS 2 58 17.2% (10) NI-RADS 3 32 59.4% (19) Combined, all categories 618 7.9% (49)